Delivery Order SPE2DB22D3301-SPE2DB26FX3SM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $3,941.37 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Brilinta 60 mg tablets (60-count units) valued at $1,211.20 under a firm fixed-price contract type. This delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.999 billion through December 2026), represents a competitively awarded, non-set-aside procurement. The place...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (100 unit dose packages) on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,556.35 on September 18, 2025, for the supply of Brilinta 90 mg tablets (60-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Brilinta 60 mg tablets (quantity 60 count) valued at $1,664.52. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The order is due for completion by September 16, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,890.12 to AmerisourceBergen Drug Corp for supply of Brilinta 60 mg tablets (60-count units) with an ultimate completion date of July 30, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader federal pharmaceutical supply framework. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Brilinta 90 mg tablets (60-count packaging) with a firm fixed price of $1,780.53 and an ultimate completion date of October 24, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX3SMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,180.17 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast array of pharmaceutical products and medical supplies to military healthcare systems and other federal agencies worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 10/22/25 |